Skip to main content

Day: January 29, 2021

SRAX (NASDAQ: SRAX) Changing Dynamic as Retail Traders Set New Records

NEW YORK, Jan. 29, 2021 (GLOBE NEWSWIRE) — via InvestorWire — SRAX (NASDAQ: SRAX) today announces its placement in an editorial published by NetworkNewsWire (“NNW”), one of 50+ trusted brands within the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities.To view the full publication, “Trade Volume Explodes as Retail Traders Make Their Mark,” please visit: https://nnw.fm/bEaWXEvidence points to increased retail trading as the primary impetus in the record-setting increase in volume with much of the real volume increase coming from little-known names in the small cap market. Electronic brokers are hitting new highs as investment markets become more retail driven, and independent investors are making marks in their own portfolios. This new dynamic puts new pressure...

Continue reading

WisdomTree Announces Fourth Quarter 2020 Results – Diluted Loss Per Share of ($0.10), or Earnings Per Share of $0.06, as adjusted

NEW YORK, Jan. 29, 2021 (GLOBE NEWSWIRE) — WisdomTree Investments, Inc. (NASDAQ: WETF) today reported financial results for the fourth quarter of 2020.($13.5) million net loss ($9.21million net income, as adjusted), see “Non-GAAP Financial Measurements” for additional information.$22.4 million of non-cash charges, associated with the revaluation of deferred consideration – gold payments.$67.4 billion of ending AUM, an increase of 11.0% arising from market appreciation and net inflows.$881 million of net inflows, driven by inflows into our emerging markets equity and U.S. equity products, partly offset by outflows from our fixed income, commodity, international developed market equity and leveraged & inverse products.0.41% average global advisory fee, a decrease of 1 basis point due to AUM mix shift.$67.1 million of operating...

Continue reading

Stifel Reports Record Fourth Quarter and Full-Year Results

25th consecutive year of record net revenues of $3.8 billion, an increase of 12.4% compared with 2019.Quarterly record net revenues of $1.1 billion, an increase of 20.0% over the third quarter of 2020.Record quarterly net income available to common shareholders of $180.8 million, or $1.55 per diluted common share.(1)Record non-GAAP net income available to common shareholders of $195.1 million, or $1.67 per diluted common share.(1)Record client assets of $357.4 billion, increased 8.5% compared with the year-ago quarter.Annualized return on average tangible common shareholders’ equity(2) was 30.8%.Non-GAAP annualized return on average tangible common shareholders’ equity(2) was 33.3%.Increasing quarterly dividend by approximately 32% to $0.15 per common share starting in first quarter of 2021.ST. LOUIS, Jan. 29, 2021 (GLOBE NEWSWIRE) —...

Continue reading

AC Immune Reports Progress for Therapeutic Programs Targeting the NLRP3 Inflammasome Pathway

Highly potent in vivo anti-inflammatory activity demonstrated for novel small molecule NLRP3 inhibitorsHigh-affinity antibodies against extracellular components of the inflammasome pathway show inhibition of target inflammatory responsesLAUSANNE, Switzerland, Jan. 29, 2021 (GLOBE NEWSWIRE) — AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, today announced recent advancements in its small molecule- and antibody-based therapeutic programs targeting the (NOD)-like receptor protein 3 (NLRP3) inflammasome, a multi-protein complex that activates downstream inflammatory pathways leading to neuronal damage. The inflammasome is a highly valued therapeutic target implicated in a wide range of neurodegenerative disorders including Alzheimer’s disease...

Continue reading

Akoustis Receives Volume Order from a Third Tier-1 Customer for Its 5.5/6.5 GHz WiFi 6E XBAW Coexistence Filter Solutions

– Tandem WiFi 6E BAW Coexistence RF Filters to Be Used in New MU-MIMO Router Product –– Customer’s Product Expected to Enter Production in Second Half of CY2021 –– XBAW Filter Solution Offers Superior Coexistence Enabling Use of Entire New WiFi 6E Frequency Spectrum –Charlotte, N.C., Jan. 29, 2021 (GLOBE NEWSWIRE) — Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless applications, announced today that it has received a volume order for its 5.5 GHz and 6.5 GHz XBAW® WiFi 6E filter solutions from a new tier-1 customer.The 5.5 GHz filter module covers the entire 5.1 to 5.8 GHz spectrum of the WiFi 6E standard, while the 6.5 GHz filter module covers the entire 5.9 to 7.1 GHz spectrum....

Continue reading

Orchard Therapeutics Appoints Braden Parker as Chief Commercial Officer

BOSTON and LONDON, Jan. 29, 2021 (GLOBE NEWSWIRE) — Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced the appointment of Braden Parker to the role of Chief Commercial Officer (CCO). In this capacity, Mr. Parker will oversee all aspects of commercial strategy, planning and operations for the company. Mr. Parker is a seasoned commercial leader with more than 20 years of experience in the healthcare and biotech industry, including deep rare disease and gene therapy experience. Mr. Parker’s previous positions include commercial leadership roles at Celgene, NPS Pharma (Shire) and PTC Therapeutics, where he led the company’s first U.S. product launch in Duchenne muscular dystrophy and oversaw the strategic planning for their gene therapy business. Most recently, Mr. Parker served as Orchard’s senior vice...

Continue reading

First National Corporation Reports Fourth Quarter 2020 Financial Results

STRASBURG, Va., Jan. 29, 2021 (GLOBE NEWSWIRE) — First National Corporation (the “Company” or “First National”) (NASDAQ: FXNC), the bank holding company of First Bank (the “Bank”), reported unaudited consolidated net income of $3.2 million, or $0.65 per diluted share, for the fourth quarter of 2020, which resulted in a return on average assets of 1.31% and a return on average equity of 15.03%. This compares to net income of $2.7 million, or $0.55 per diluted share, and a return on average assets of 1.36% and a return on average equity of 14.10% for the fourth quarter of 2019. Recovery of loan losses of $200 thousand and provision for loan losses of $250 thousand were included in net income for the three-month periods ending December 31, 2020 and 2019, respectively.For the year ending December 31, 2020, net income totaled $8.9 million,...

Continue reading

Form 8.3 – [Scapa Group plc] – (CGWL)

FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1.         KEY INFORMATION2.         POSITIONS OF THE PERSON MAKING THE DISCLOSUREIf there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)All interests and all short positions should be disclosed.Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should...

Continue reading

Amerant Bancorp Inc. Reports Fourth Quarter and Full-Year Results

CORAL GABLES, Fla., Jan. 29, 2021 (GLOBE NEWSWIRE) — Amerant Bancorp Inc. (NASDAQ: AMTB and AMTBB) (the “Company” or “Amerant”) today reported net income of $8.5 million in the fourth quarter of 2020, compared to net income of $1.7 million reported in the third quarter of 2020 and net income of $13.5 million reported in the fourth quarter of 2019. Net loss for the full-year 2020 was $1.7 million, compared to net income of $51.3 million for the full-year 2019. Net loss for the full-year 2020 was primarily driven by $88.6 million in provision for loan losses during the period. Operating income was $7.5 million in the fourth quarter of 2020, compared to $11.5 million in the third quarter of 2020 and $14.8 million in the fourth quarter of 2019. Operating income was $57.3 million in the full-year 2020, compared to $58.3 million in the...

Continue reading

Bombardier Closes Sale of its Transportation business to Alstom

Net proceeds to Bombardier of ~$3.6 billion, including ~$600 million in Alstom sharesProceeds strengthen liquidity and will allow the Company to begin debt paydown1; Pro-forma net debt as of December 31, 2020 ~$4.7 billion2 Completes Bombardier’s repositioning as a pure-play business jet companyAll amounts in this press release are in U.S. dollars unless otherwise indicated. Amounts in EUR in this press release are converted to USD at an exchange rate of 1.22, except for certain transaction cash proceeds fixed at an exchange rate of 1.17.MONTREAL, Jan. 29, 2021 (GLOBE NEWSWIRE) — Bombardier (TSX: BBD.B) confirmed today the closing of the previously announced sale of its Transportation business to Alstom.Total proceeds to the vendors after the deduction of debt-like items and transferred liabilities are $6.0 billion3. After deducting...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.